This course is no longer available for credit on our site. Explore our online catalog to view more courses
On Demand
Unlimited

Yours, Mine and Ours: Supreme Court Speaks on the Patentability of Human Genes

1h 1m

Created on November 14, 2014

Intermediate

Overview

Last  summer,  the  Supreme  Court  issued  its  decision  in  Association for Molecular Pathology, et al. v. US Patent and Trademark Office, Myriad Genetics, et al, S. Ct.  2107  (2013),  regarding whether human genes are patentable. Although the Court held that isolated, naturally-occurring DNA  segments  are  unpatentable  products  of  nature,  that  is  not  the  end  of  the  story  for the  biotech  industry.  The  Court  also  held  that  non-naturally  occurring  DNA  segments  are patentable. 

 

This course explores the Courts’ decision and its effect on the current set of court challenges: the patentability of DNA segments in the context of primers (DNA strands that jumpstart DNA replication) and probes  (which are primers with an attachment). The course also evaluates the new US Patent Office Guidelines issued on March 4, 2014.

 

Learning Objectives:

I.   Understand  the Supreme Court decision in Association for Molecular Pathology, et  al. v. US Patent and Trademark Office, Myriad Genetics, et al, S. Ct. 2107 (2013)

II.  Grasp  the  patentability  of  DNA  segments  in  the  context  of  primers  (DNA  strands  that  jumpstart  DNA  replication)  and  probes  (which  are  primers  with  an attachment)

III. Evaluate the new US Patent Office Guidelines issued on March 4, 2014

Gain access to this course, plus unlimited access to 1,800+ courses, with an Unlimited Subscription.

Explore Lawline Subscriptions